NovaMedica Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • 2ndary - Private

NovaMedica General Information

Description

Operator of a drug discovery and commercialization platform designed to commercialize products that have significant value in the market. The company's platform engages in building a portfolio of services to unmet needs across the growing therapeutic areas, also engaged in working with a number of its own drug products that are at various stages of development such as from creation of a dosage form to clinical studies, state registration and market launch, enabling customers to avail enhanced products for the treatment of chronic illness and diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 8, 2-nd Brestskaya street
  • Moscow, 125196
  • Russia
+7 8
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 8, 2-nd Brestskaya street
  • Moscow, 125196
  • Russia
+7 8

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaMedica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
1. Seed Round 06-Mar-2012 Completed Generating Revenue
To view NovaMedica’s complete valuation and funding history, request access »

NovaMedica Patents

NovaMedica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024043809-A1 Pharmaceutical composition containing gabapentin and benfotiamine and dosage form based thereon Inactive 26-Aug-2022
WO-2022154687-A1 Pharmaceutical composition containing esomeprazole Inactive 14-Jan-2021
EP-4190319-A1 Pharmaceutical composition comprising memantine and citicoline Inactive 29-Jul-2020
EP-4190319-A4 Pharmaceutical composition comprising memantine and citicoline Inactive 29-Jul-2020
WO-2022025785-A8 Pharmaceutical composition comprising memantine and citicoline Inactive 29-Jul-2020 A61P25/00
To view NovaMedica’s complete patent history, request access »

NovaMedica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovaMedica FAQs

  • When was NovaMedica founded?

    NovaMedica was founded in 2012.

  • Where is NovaMedica headquartered?

    NovaMedica is headquartered in Moscow, Russia.

  • What is the size of NovaMedica?

    NovaMedica has 60 total employees.

  • What industry is NovaMedica in?

    NovaMedica’s primary industry is Drug Discovery.

  • Is NovaMedica a private or public company?

    NovaMedica is a Private company.

  • What is NovaMedica’s current revenue?

    The current revenue for NovaMedica is .

  • How much funding has NovaMedica raised over time?

    NovaMedica has raised $15M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process